Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: Risk factor analysis and implications for screening and prophylaxis

Cytopathology

Volumn 20, Issue 4, 2009, Pages 249-255

  Gupta, S ^a   Sodhani, P ^a   Sharma, A ^a   Sharma, J K ^a   Halder, K ^a   Charchra, K L ^a   Sardana, S ^a   Singh, V ^a   Sehgal, A ^a   Das, B C ^a  

^a Institute of Cytology and Preventive Oncology ICMR   (India)

Author keywords

Cervical cancer screening; Cytology; Epidemiology; High risk; Human papillomavirus; Risk factors

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SCREENING TEST; TERTIARY HEALTH CARE; UTERINE CERVICITIS; UTERINE CERVIX CANCER;

ADULT; CERVIX UTERI; EARLY DETECTION OF CANCER; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 68149105823     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2008.00611.x     Document Type: Article

References (33)

1. Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN 2002 (eds). Cancer Incidence, Mortality and Prevalence Worldwide. Version 2.0 IARC Cancer Base No. 5. Lyon, France : International Agency for Research on Cancer Press 2004.
2. Parkin DM. The global health burden of infection associated cancers in the year 2002. Int J Cancer 2006 118 : 3030 44.
3. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999 189 : 12 9.
4. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995 76 : 1888 901.
5. Bosch FX, Qiao YL, Catellsague X. The epidemiology of human papillomavirus infection and its association with cervical cancer. Int J Gynecol Obstet 2006 94 (Suppl. 1 S8 21.
6. Mayrand M-H, Duarte-Franco E, Rodrigues I et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007 357 : 1579 88.
7. Clifford GM, Gallus S, Herrero R et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005 366 : 991 8.
8. Solomon D, Davey DD, Kurman R et al. (Forum Group members) Bethesda 2001 Workshop: The 2001 Bethesda System: terminology for reporting the results of cervical cytology. JAMA 2002 287 : 2114 7.
9. Arora R, Kumar A, Prusty BK et al. Prevalence of high-risk human papilloma virus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Obstet Gyencol Reprod Biol 2005 121 : 104 9.
10. Das BC, Sharma JK, Gopalkrishna V et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 1992 36 : 239 45.
11. Rolon PA, Smith JS, Munoz N et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000 85 : 486 91.
12. Cibas ES, Hong X, Crum CP, Feldman S. Age specific detection of high-risk HPV DNA in cytologically normal, computer-imaged Thin Prep Pap samples. Gynecol Oncol 2007 104 : 702 6.
13. Evans MF, Adamson CSC, Papillo JL et al. Distribution of human papillomavirus types in Thin Prep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006 106 : 1054 64.
14. Thomas JO, Herrero R, Omigbodun AA et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004 90 : 638 45.
15. Bulkmans NW, Rozendaal L, Snijders PJ et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 2004 110 : 94 101.
16. Molano M, Posso H, Weiderpass E et al. Prevalence and determination of HPV infection among Colombian women with normal cytology. Br J Cancer 2002 87 : 324 33.
17. Lazcano-Ponce E, Herrero R, Munoz N et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001 91 : 412 20.
18. Levert M, Clavel C, Graesslin O et al. Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients. Gynecol Obstet Fertil 2000 28 : 722 8.
19. Jacobs MV, Walboomers JM, Snijders PJ et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000 87 : 221 7.
20. Kjaer SK, van den Brule AJ, Bock JE et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and non-oncogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997 6 : 799 805.
21. Melkert PW, Hopman E, van den Brule AJ et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993 6 : 919 23.
22. Solomon D, Schiffman M, Tarone R. The ALTS Study Group comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001 93 : 293 9.
23. Sarnath D, Khan Z, Tandle AT et al. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical patients from India. Gynecol Oncol 2002 86 : 57 62.
24. Aggarwal R, Gupta S, Nijhawan R et al. Prevalence of high-risk human papillomavirus infection in women with benign cervical cytology: a hospital based study from North India. Indian J Cancer 2006 43 : 110 6.
25. Franceschi S, Rajkumar T, Vaccarella S et al. Human papilloamvirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 2003 107 : 127 33.
26. Duttagupta C, Sengupta S, Roy M et al. Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. Int J Gynecol Cancer 2004 14 : 293 303.
27. Gopalkrishna V, Aggarwal N, Malhotra VL et al. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Clin Microbiol Infect 2000 6 : 88 93.
28. Das BC, Gopalkrishna V, Das DK et al. Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women. Cancer 1993 72 : 147 53.
29. Gupta S, Sodhani P, Halder K et al. Age trends in pre-cancerous and cancerous lesions of uterine cervix in a cytology screening programme: what should be the target age group for a major thrust of screening in resource-limited settings? Cytopathology 2008 19 : 606 10.
30. Franceshi S, Herrero R, Clifford GM et al. and the IARC HPV Prevalance Surveys Study Group. Variation in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006 119 : 2677 84.
31. Das BC, Sehgal A, Murthy NS et al. Human papillomavirus and cervical cancer in Indian women. Lancet 1989 2 : 1271.
32. Masumoto N, Fujii T, Ishikawa M et al. Dominant human papillomavirus infection in cervical neoplasia in young Japanese women; study of 831 outpatients. Gynecol Oncol 2004 94 : 509 14.
33. Murthy NS, Sehgal A, Satyanarayana L et al. Risk factors related to biological behavior of precancerous lesions of the uterine cervix. Br J Cancer 1990 61 : 732 6.